Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-02

Clinical Trial Update: Peri-neural Dexmedetomidine as an Adjuvant to Bupivacaine Induced Paravertebral Block in Patients Undergonig Thoracotomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perineural dexmedetomidine as an adjuvant to bupivacaine for paravertebral block in thoracotomy patients has completed. The study targe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Cairo University | Conditions: Acute Post-thoracotomy Pain | Phase 2 | Status: COMPLETED